NCT02064673View on ClinicalTrials.gov

Adjuvant Curcumin to Assess Recurrence Free Survival in Patients Who Have Had a Radical Prostatectomy

PHASE3RecruitingINTERVENTIONAL
Enrollment

608

Participants

Timeline

Start Date

May 31, 2014

Primary Completion Date

June 30, 2028

Study Completion Date

December 31, 2028

Conditions
Prostate Cancer
Interventions
DRUG

Curcumin

Curcumin or placebo 500mg by mouth twice a day for 6 months

DRUG

placebo

placebo orally twice a day

Trial Locations (1)

75390

RECRUITING

UT Southwestern Medical Center, Dallas

All Listed Sponsors
lead

yair lotan

OTHER